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Introduction Introduction
Colorectal cancer (CRC) is responsible for 8% of total cancer-related deaths worldwide (1) . Most CRCs are known to develop as a consequence of the adenoma-carcinoma sequence (2) (3) (4) . Diagnosis of early stage CRC has a critical importance in terms of 5-year survival rates alter from 5% to 96% according to stage of disease (5) . The efforts for seeking a biochemical marker that has both diagnostic and predictive value for the extent of disease are still ongoing.
Neutrophil gelatinase-associated lipocalin (NGAL) is a 25-kDa protein that is stored in human neutrophil granules, which acts as a modulator of inflammation (6) . It has been ascertained that NGAL is expressed in many types of cells and plays a role in various processes such as growth, development, and differentiation of these cells (7) (8) (9) (10) (11) . The diagnostic and prognostic potential of NGAL appears variable and contradictory according to the type of cancer. Studies that performed on thyroid, breast and endometrial tissue samples showed that NGAL expression increases in the presence of neoplasia or dysplasia (12) (13) (14) (15) (16) (17) . Immunohistochemical staining experiments revealed that NGAL expression in normal tissue was null or weak in 98% of cases, whereas it was moderate or intense in 74% of cancer tissue (18) . NGAL expressions are increased in CRC and benign inflammatory diseases such as inflammatory bowel disease (19) (20) (21) (22) . Several studies observed the prognostic importance of NGAL expression on tissue samples (19, (23) (24) (25) .
Recent studies regarding to plasma NGAL level showed that, increased plasma levels are related with cancer patients than in healthy controls (26, 27) . But examined serum NGAL levels revealed discordant results. Sun et al, did not show ay significance increase in plasma NGAL levels in CRC patients. Conversely, Fung et al (28) , reported moderately higher plasma NGAL level without correlation with "T" stage. There are only few studies in current literature that evaluates the relationship between serum NGAL level and CRC (18, 28, 29) . The aim of this study was to evaluate the significance of serum NGAL levels as a diagnostic and predictive biomarker in patients with CRC.
Materials and Methods

This study was performed in General surgery department of Istanbul Medeniyet University, Goztepe Education and Research hospital, between January 2011 and December 2012. Ninety patients were planned to classified into 3 groups as the "Cancer group (CAG)", the "Polyp group (PG)", and the "Control group (COG)". Subjects with pre-operatively known distant metastasis or if they have active infection, history of renal or pancreatic diseases, concomitant other organ cancers, hemolysis blood samples, and patients had received neoadjuvant chemotherapy or radiotherapy were excluded from the study. Plasma creatinine levels were detected simultaneously, to avoid biases from NGAL increases during renal failure. Patients with less than 12 harvested lymph node and patients with polyps smaller than 1 cm diameter on pathological examination were also excluded from the assessment.
Totally 80 patients were included the study. Twenty-seven patients consecutively admitted for elective surgery and underwent curative resections for CRC were classified as CAG. Twenty-four patients who were detected colorectal polyps greater than 1cm in diameter during colonoscopy were classified as PG, and colonoscopic polypectomy was performed to all patients. We performed colonoscopy to the patients in control group to exclude the presence of inflammatory bowl disease, and 29 patients with no pathological findings during colonoscopy were classified as the COG.
Blood samples were obtained before the surgery for the CRC patients, and before the polypectomy for patients at polyp group. Blood samples were immediately stored at +4°C, and analyses were blinded. Serum NGAL, carcinoembryonic antigen (CEA) and cancer antigen 19-9 (CA19-9) levels were detected to evaluate the significance of serum NGAL levels regarding to the adenoma-carcinoma sequence of CRC. Serum NGAL levels were determined using Human NGAL/ Lipocalin-2 ELISA kit (Santa Clara, CA Cat. No.SK00233-01) in accordance with the manufacturer's protocol.
Tumor size and grade, cancer stage, presence of lymphovascular invasion, number of metastatic lymph nodes and presence of distant metastasis in CRC patients were investigated in the study. The Mann Whitney U test was used in the determination of the groups, which caused the difference and the compassions of the parameters to show abnormal distribution between the groups. Spearman's rho correlation coefficient was used for the correlation of the analysis between the parameters. ROC curve was performed to represent a sensitivity/specificity pair corresponding to a particular decision threshold. Results were reviewed in a confidence interval of 95%, and a value of p<0.05 was accepted as statistically significant.
This study was approved by the Scientific Ethics Committee of the Istanbul Medeniyet University, School of Medicine. All the procedures were in accordance with the ethical standards of the responsible committee on human experimentation and with the Helsinki Declaration of 1975, which was revised in 1983.
Results Results
Eighty patients, 42 (52.5%) male and 38 (47.5%) female, with a mean age of 55.9±14.7 years were included in the study. There were no statistically difference between control group and other groups according to age and sex.
Serum NGAL levels of the patients in CAG, PG and COG were determined and presented on a scatter plot graph (Fig. 1) . Mean NGAL levels of these three groups were calculated as 184.29 ng/mL, 139.57 ng/mL and 91.46 ng/mL; respectively and compared statistically ( Table 1) . NGAL levels were statistically significant difference between groups (p:0.013). The Mann-Whitney U test was used to perform binary group analysis to determine the reason for statistical significance. Hereby, serum NGAL levels of the patients in CAG were detected significantly higher than the patients in COG (p: 0.006). Five of the 80 patients' NGAL levels were higher than the "mean serum NGAL value+2SD". They excluded from the groups to standardize the results, and re-analysis demonstrated that NGAL levels of patients in CAG was still statistically higher than COG (p:<0.001). Patients separated into two groups such as patients with CRC or polyp with high-grade dysplasia considered as a group and patients with low-grade dysplasia or normal colonoscopy findings the other group. ROC analysis was performed to define the cut-off value of serum NGAL (Fig. 2) . ROC analysis revealed that the discriminative power of serum NGAL level between CRC and control group assessed by an area under the curve (AUC) of Serum CEA and CA19-9 levels of patients in CAG were determined significantly higher than patients in COG (p: 0.001 and p: 0.003; respectively). But there was no significant difference between patients in CAG and patients in PG according to serum CEA and CA19-9 levels ( Table 1) . Although not statistically significant difference, the patients in PG had lower NGAL levels compared to CAG, and had higher NGAL levels compared to COG (p: 0.248 and p: 0.166, respectively). On the other hand serum CEA levels of the patients in PG were detected significantly higher when compared with COG (p:0.008).
Patients in PG were separated into two subgroups according to their degrees of dysplasia, such as "Low-grade" and "Highgrade" ( Table 2 ). Eight of the 24 patients in PG had "Highgrade" dysplasia and the mean NGAL level was detected 198.04ng/ml. The mean NGAL level of patients with "Lowgrade" dysplasia was detected 110.33ng/ml. Statistically significant difference was not detected between these subgroups in terms of serum NGAL levels (p:0.154).
Eight of the patients with CRC underwent laparoscopic surgery, while the others open surgery. There was no statistically significant correlation detected between serum NGAL levels and age in CAG ( Table 3) . When we compared serum NGAL levels with tumor-related features, statistically significant and positive correlational relationship was detected with tumor size (r:0.38, p:0.047) and the number of metastatic lymph nodes (r:0.42, p:0.026) (Fig. 3) . But we did not detect significant correlation between NGAL other tumor features such as tumor Table 4) . There was statistically significant difference and positive correlation detected between serum NGAL level and "N" stage according to the TNM classification system. In consequence of the comparisons that were carried out to determine the group which caused the statistically difference, serum NGAL levels of patients with "N2" stage were significantly higher than patients with "N0" stage (p:0.017) ( Table 5 ). Statistical analysis of serum NGAL levels could not be carried out with the "T" stages because of the limited number of patients at "T2" and "T4" stages.
Discussion Discussion
NGAL is a protein that stored in neutrophil granules with a weight of 25-kDa5. NGAL is characterized by the ability to bind and transport lipophilic substances. It is included in the lipocalin family, which has more than 50 members (8) . NGAL delivers iron to the cytoplasm, and also provides its uptake through the specific membrane receptors (30, 31) . NGAL also plays a strategic role for immune defense against bacterial pathogens by reducing the amount of iron when released from activated neutrophils (32) . Additionally, NGAL regulates critically important genes that effect cellular differentiation. Therefore, it participates in the growth, development and differentiation of tissues, beginning from the embryonic period (7-10). Hu et al. determined that NGAL decreases E-cadherin mediated cell-cell adhesion, so increases cellular motility and invasion property of carcinoma cells (21) . It is revealed that synthesis of NGAL is induced by various factors that may cause neoplasia (8, 10, 33) .
Sun et al. stated a statistically significant increase of NGAL expression on tissue samples of 526 patients during adenoma-carcinoma sequence. The increase was particularly evident at the stage of transition zone from low-grade to highgrade dysplasia (25) . In our study, no statistically significant difference was observed between the high-grade and low-grade dysplasia subgroups regarding to serum NGAL levels (p:0.154). Also we did not detect any statistically significant differences between PG and CAG or COG (p:0,248, and p:0.166, respectively). We need more comprehensive studies to determine whether increased serum NGAL levels occur during the adenoma-carcinoma sequence or not.
Lee et al. reported that elevated CEA levels accompanied by anemia has a predictive significance for CRC, but it did not constitute significance for patients with colon polyps (34) . In our study, CEA levels in PG were significantly higher than COG (p:0,008). Serum NGAL levels in CAG were also higher than the other groups, as consistent with CEA and CA19-9. Positive correlation between the serum NGAL levels and other cancer biomarkers such as serum CEA and CA19-9 levels may support the predictive and diagnostic significance of serum NGAL level.
Tumor size and number of metastatic lymph nodes are known to be the most important prognostic indicators for patients with CRC. However, necessity of biomarker that has prognostic significance for preoperatively staging of CRC is ongoing. Recent articles have revealed that NGAL plays an important role in development of gastrointestinal system cancers such as esophagus and gastric cancer. However, its role in CRC is still unclear (19, (23) (24) (25) . Recent studies have revealed an increased level of NGAL expression in the resection specimens of cancer patients (22, (35) (36) (37) . Some other studies have shown that NGAL mRNA levels have a positive correlation with advanced stage CRC (19, 21) . Additionally, İt's demonstrated that overexpression of NGAL decreases intercellular connections, and increases tumor invasion, cell-matrix combination and cellular motility in vitro (21) . Nevertheless, there are inconsistent and even contradictory reports on the role of NGAL in the development and progression of cancer. Various studies were presented in the literature about genetic and immunohistochemical analyses on tissue samples to evaluate the diagnostic value of NGAL in CRC (19, 21, 25, (38) (39) (40) . However, there is only one study available in current literature to evaluate the relationship between serum NGAL level and CRC. Researches are still being conducted to find easily applicable blood tests in order to diagnose either early stage colorectal cancer or ongoing adenoma-carcinoma sequence. There are only few studies reported that evaluates differences of serum NGAL levels during adenoma-carcinoma sequence. Duvillard et al (18) demonstrated that serum NGAL levels are detected statistically significant higher in patients with CRC, especially elevated in patients with large tumors. Marti et al (29) reported that metastatic and non-metastatic colorectal cancer patients had higher serum NGAL levels than healthy controls. Likewise, our study revealed that existence of CRC, larger tumor size and number of metastatic lymph nodes are statistically significant correlated with serum NGAL levels. Duvillard et al. detected optimal NGAL cut-off value was 106 ng/mL, with 60% specificity and 70% sensitivity. We revealed similar results that an optimal cut-off value was 103.55 ng/mL, with 68.9% specificity and 71.4% sensitivity. Increased tumor size and the number of metastatic lymph nodes are known to be associated with advanced stage disease and poor prognosis in CRC (41, 42) . Sun et al. reported that there was no statistically significant correlation between tumor diameter and NGAL expression levels in tissue samples of patients with CRC (25) . Our study revealed that serum NGAL level has a statistically significant and positive correlational relationship with tumor size (r:0.38, p:0.047) and the number of metastatic lymph nodes (r:0.42, p:0.026) (Fig. 3) .
The presence of lymphovascular and perineural invasion increases the risk of lymph node metastasis, as an independent prognostic factor adversely affecting survival (43, 44) . Similar studies have been carried out to investigate the correlation between prognosis and lymphovascular or perineural invasion (44, 45) . Our study has limited number of patients with lymphovascular or perineural invasion. As a result, we did not detect statistically significant correlation between serum NGAL levels and lymphovascular or perineural invasion (p:0.614, p:0.195, respectively).
Studies have been carried out to compare the NGAL expression levels in CRC with other tumor features such as cancer differentiation and localization of the tumor. As a result of these studies there were no significant correlations between NGAL expression level and tumor localization or cancer differentiation (25, 39) . Likewise, we did not find a correlation between serum NGAL levels and these features.
TNM staging system is the most commonly used staging system to predict the prognosis of patients with CRC (41, 42) . The correlation between TNM staging system and NGAL expression was also examined in several studies and it was concluded that advanced stage tumors were associated with higher NGAL expression levels and poorer prognosis (25, 40) . Serum NGAL level and "N" stage of patients with CRC was compared in our study. Increased serum NGAL levels were significantly associated with increased number of metastatic lymph nodes (p:0.026). Also statistically significant difference was found between advanced "N" stages and increased serum NGAL levels (p:0.048). We ascertained that the serum NGAL levels of the patients with "N2" stage were significantly higher than those with "N0" stage (p:0.017).
This study revealed no statistically significant difference between the patients with low-grade dysplasia and high-grade dysplasia in PG according to serum NGAL levels. Additionally, no significant correlation between NGAL levels and the adenoma-carcinoma sequence was revealed. Although this study has some limitations such as the number of patients, serum NGAL level was significantly higher in patients with CRC, suggests that the diagnostic value of serum NGAL for CRC. Moreover, the significant positive correlation between serum NGAL levels and well-known prognostic indicators such as the number of metastatic lymph nodes and tumor size may also supports the prognostic value of serum NGAL levels for CRC patients.
Conclusions Conclusions
In conclusion, preoperative detection of serum NGAL level is an easy applicable test, and 103.55ng/mL cut-off value of serum NGAL for CRC or high-grade dysplasia is detected with 68.9% specificity and 71.4% sensitivity. Although more comprehensive studies are needed for definitive judgments, serum NGAL levels may be used as a diagnostic biomarker and/or predictive test for lymph node metastasis in patients with CRC.
